Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma

BACKGROUND: Osteosarcoma is the most common primary malignant bone tumor in children and adolescents. For effective treatment, local control of the tumor is absolutely critical, because the chances of long term survival are <10% and might effectively approach zero if a complete surgical resection...

Descripción completa

Detalles Bibliográficos
Autores principales: Blattmann, Claudia, Oertel, Susanne, Schulz-Ertner, Daniela, Rieken, Stefan, Haufe, Sabine, Ewerbeck, Volker, Unterberg, Andreas, Karapanagiotou-Schenkel, Irini, Combs, Stephanie E, Nikoghosyan, Anna, Bischof, Marc, Jäkel, Oliver, Huber, Peter, Kulozik, Andreas E, Debus, Jürgen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846886/
https://www.ncbi.nlm.nih.gov/pubmed/20226028
http://dx.doi.org/10.1186/1471-2407-10-96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846886/
https://www.ncbi.nlm.nih.gov/pubmed/20226028
http://dx.doi.org/10.1186/1471-2407-10-96

Ejemplares similares